Literature DB >> 25267764

Raised levels of immunoglobulin G, A and M are associated with an increased risk of total and cause-specific mortality: the Vietnam Experience Study.

Anna C Phillips1, Douglas Carroll1, Mark T Drayson2, G David Batty3.   

Abstract

BACKGROUND: Immunoglobulins (Ig) are essential for combating infectious disease. However, high levels are associated with a range of diseases and/or poor health behaviours, such as autoimmune diseases, chronic infection, HIV and excessive alcohol consumption. In the present analyses, we extend this body of work by examining whether higher levels of serum Ig G, A and M are associated with increased mortality risk.
METHODS: Participants were 4255 Vietnam-era, former US army personnel (the Vietnam Experience Study). From military service files, telephone interviews in 1983 and a medical examination in 1986, sociodemographic, and health data were collected. Contemporary morning fasted blood samples were taken from which IgG, IgA and IgM concentrations were determined. Mortality surveillance over 15 years gave rise to deaths ascribed to all-causes, cardiovascular disease mortality, all cancers combined mortality, external cause and 'other' causes (predominantly comprising deaths due to infectious disease). Cox proportional hazard models were utilised to compute HRs per SD increase in Ig which were first adjusted for age and then additionally adjusting for a range of candidate confounders.
RESULTS: In multiply adjusted analyses, in general, the higher the immunoglobulin concentration, the greater the risk of death. Thus, IgA (HR=2.0 95% CI 1.47 to 2.73), IgM (HR=1.5 95% CI 1.11 to 1.91) and IgG (HR=5.8 95% CI 3.38 to 9.95) were positively related to all-cause mortality. Corresponding results for 'other' causes of mortality were 4.7 (2.64 to 8.19), 3.5 (2.29 to 5.45) and 33.4 (15.13 to 73.64).
CONCLUSIONS: In the present study, high levels of Ig are associated with an elevated risk of death from total and 'other' causes, mainly infectious disease. High levels of Ig, particularly IgG, may signal subclinical disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  INFECTION; Life course epidemiology; MORTALITY

Mesh:

Substances:

Year:  2014        PMID: 25267764     DOI: 10.1136/jech-2014-204345

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  4 in total

1.  Serum Immunoglobulins, Pneumonia Risk, and Lung Function in Middle-Aged and Older Individuals: A Population-Based Cohort Study.

Authors:  Samer R Khan; Anna Vanoverschelde; Lies Lahousse; Robin P Peeters; P Martin van Hagen; Guy Brusselle; Layal Chaker; Virgil A S H Dalm
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

2.  Under-5-Minute Immunoblot Assays by Vortex Fluidic Device Acceleration.

Authors:  Emily C Sanders; Sanjana R Sen; Aidan A Gelston; Alicia M Santos; Xuan Luo; Keertna Bhuvan; Derek Y Tang; Colin L Raston; Gregory A Weiss
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-12       Impact factor: 16.823

3.  Salivary Immunoglobulin A Secretion Rate Is Negatively Associated with Cancer Mortality: The West of Scotland Twenty-07 Study.

Authors:  Anna C Phillips; Douglas Carroll; Mark T Drayson; Geoff Der
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

4.  Clinical Immunophenotype at Disease Onset in Previously Healthy Patients With Cryptococcal Meningitis.

Authors:  Lie Xu; Qin Huang; Jin-Ran Lin; Cui-Yun Zhu; Xin-Hua Li; Shan-Ke Ye; Ai-Hong Zhu; Dai-Hong Chen; Cheng-Feng Zhang; Liang Chen; Yun Ling
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.